Mulvihill ETFs - XLVE: U.S. Health Care Enhanced Yield ETF

Mulvihill's XLVE ETF offers exposure to large-cap US healthcare stocks with 25% leverage used for purchasing additional shares to write options, generating income from option premiums while maintaining close to "full" exposure to underlying portfolio stocks.

Mulvihill ETFs - XLVE: U.S. Health Care Enhanced Yield ETF

Gain Access to High-Yield Healthcare Investing with Mulvihill's XLVE ETF

Mulvihill's XLVE ETF offers exposure to large-cap US healthcare stocks with 25% leverage used for purchasing additional shares to write options, generating income from option premiums while maintaining close to "full" exposure to underlying portfolio stocks. This combination provides yield enhancement benefits of option writing strategies without sacrificing upside potential in rising markets. Additionally, the ETF hedges US dollar exposure back to Canadian dollars.XLVE is a new ETF by Mulvihill that offers exposure to leading large cap US healthcare stocks. It has a current yield of 7% and offers monthly distributions, which is more than four times the S&P 500 Health Care Index.

For more information on Mulvihill ETFs (TSX: XLVE) please click on the request investor info button.


No items found.

You might also like

Erdene Resource Development Builds Multi-Commodity District in Mongolia
Metals & Mining
February 12, 2026

Erdene Resource Development Builds Multi-Commodity District in Mongolia

This is some text inside of a div block.
CEO Clips - Erdene Resource Development Advances High-Grade Gold Project in Mongolia
Metals & Mining
February 12, 2026

CEO Clips - Erdene Resource Development Advances High-Grade Gold Project in Mongolia

This is some text inside of a div block.
BOLD Ventures Actively Exploring in North Western Ontario, Canada
Metals & Mining
February 10, 2026

BOLD Ventures Actively Exploring in North Western Ontario, Canada

Ring of Fire Interest, New Discovery, Winter Drill Program

This is some text inside of a div block.
Subscribe and receive the investor Info